Effective meglumine antimoniate intralesional therapy for Chiclero's ulcer refractory to systemic liposomal amphotericin B

Michele Spinicci^{1

2}, Lorenzo Zammarchi^{1

2}, Marina Gramiccia³, Trentina Di Muccio³, Dario Bartolozzi², Paola Corsi², Michele Trotta², Alessandro Bartoloni^{1

2}

Affiliations

¹ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
² Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
³ Unit of Vector-Borne Diseases, Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Michele Spinicci et al. J Travel Med. 2021.

. 2021 Aug 27;28(6):taaa169.

doi: 10.1093/jtm/taaa169.

Michele Spinicci^{1

2}, Lorenzo Zammarchi^{1

2}, Marina Gramiccia³, Trentina Di Muccio³, Dario Bartolozzi², Paola Corsi², Michele Trotta², Alessandro Bartoloni^{1

2}

¹ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
² Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy.
³ Unit of Vector-Borne Diseases, Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

No abstract available

Keywords: Leishmania mexicana; Chiclero’s ulcer; Cutaneous leishmaniasis; Glucantime; antimonial; meglumine antimoniate.

Publication types